These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 8389181
1. Efficacy of chemoembolization for hepatocellular carcinomas: experience from the Gustave Roussy Institute and the Bicêtre Hospital. Rougier P, Roche A, Pelletier G, Ducreux M, Pignon JP, Etienne JP. J Surg Oncol Suppl; 1993; 3():94-6. PubMed ID: 8389181 [Abstract] [Full Text] [Related]
2. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study. Baur M, Walter R, Gebauer A, Tscholakoff D, Lochs H, Mühlbacher F, Turetschek K, Binder R, Hudec M, Gangl A, Ferenci P, Dittrich C. Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922 [Abstract] [Full Text] [Related]
3. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam. Ngan H, Lai CL, Fan ST, Lai EC, Yuen WK, Tso WK. Clin Radiol; 1993 May; 47(5):315-20. PubMed ID: 8389682 [Abstract] [Full Text] [Related]
4. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Seong J, Keum KC, Han KH, Lee DY, Lee JT, Chon CY, Moon YM, Suh CO, Kim GE. Int J Radiat Oncol Biol Phys; 1999 Jan 15; 43(2):393-7. PubMed ID: 10030267 [Abstract] [Full Text] [Related]
5. A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma. Imaoka S, Sasaki Y, Shibata T, Fujita M, Kasugai H, Kojima J, Ishiguro S, Ohigashi H, Ishikawa O, Fukuda I. Cancer Chemother Pharmacol; 1989 Jan 15; 23 Suppl():S126-8. PubMed ID: 2538259 [Abstract] [Full Text] [Related]
10. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Farinati F, De Maria N, Marafin C, Herszènyi L, Del Prato S, Rinaldi M, Perini L, Cardin R, Naccarato R. Dig Dis Sci; 1996 Dec 15; 41(12):2332-9. PubMed ID: 9011438 [Abstract] [Full Text] [Related]
11. [A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization]. Jung YK, Yeon JE, Kim CH, Lee HJ, Lee YS, Yoon EL, Suck JE, Choi JH, Kim JH, Byun KS. Korean J Hepatol; 2009 Sep 15; 15(3):357-61. PubMed ID: 19783885 [Abstract] [Full Text] [Related]
12. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder. Clouse ME, Stokes KR, Kruskal JB, Perry LJ, Stuart KE, Nasser IA. J Vasc Interv Radiol; 1993 Sep 15; 4(6):717-25. PubMed ID: 7506597 [Abstract] [Full Text] [Related]
15. [Chemoembolization in the therapy of hepatocarcinoma. A 3-year experience]. Savastano S, Feltrin GP, Miotto D, Chiesura-Corona M, Torraco A, Castellan L, Roman E, el Khatib AB, Cannito F, Sandri P. Radiol Med; 1992 Nov 15; 84(5):608-12. PubMed ID: 1335590 [Abstract] [Full Text] [Related]
16. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. Brown DB, Pilgram TK, Darcy MD, Fundakowski CE, Lisker-Melman M, Chapman WC, Crippin JS. J Vasc Interv Radiol; 2005 Dec 15; 16(12):1661-6. PubMed ID: 16371533 [Abstract] [Full Text] [Related]
18. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Idèo G. Hepatology; 1994 May 15; 19(5):1115-23. PubMed ID: 7513677 [Abstract] [Full Text] [Related]